YAF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.110200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.049980E-01
Normal-vs-Stage2
4.301600E-02
Normal-vs-Stage3
1.651820E-02
Normal-vs-Stage4
1.879610E-01
Stage1-vs-Stage2
6.912000E-01
Stage1-vs-Stage3
1.865990E-01
Stage1-vs-Stage4
6.777600E-01
Stage2-vs-Stage3
3.497000E-01
Stage2-vs-Stage4
4.649600E-01
Stage3-vs-Stage4
8.336000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.283900E-02
Normal-vs-AfricanAmerican
1.847350E-01
Normal-vs-Asian
2.385800E-02
Caucasian-vs-AfricanAmerican
6.545000E-01
Caucasian-vs-Asian
1.451850E-01
AfricanAmerican-vs-Asian
2.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.294300E-02
Normal-vs-Female
4.638200E-02
Male-vs-Female
7.436800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.162400E-02
Normal-vs-Age(41-60Yrs)
1.890230E-01
Normal-vs-Age(61-80Yrs)
3.115500E-02
Normal-vs-Age(81-100Yrs)
2.040500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.326600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.719000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.049400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.676190E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.460300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.958200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.580600E-03
Normal-vs-Daily Drinker
3.420900E-03
Normal-vs-Weekly Drinker
1.496410E-02
Normal-vs-Occasional Drinker
1.829230E-01
Normal-vs-Social Drinker
1.412370E-01
Non Drinker-vs-Daily Drinker
3.824000E-01
Non Drinker-vs-Weekly Drinker
7.913200E-01
Non Drinker-vs-Occasional Drinker
6.946100E-02
Non Drinker-vs-Social Drinker
3.186200E-01
Daily Drinker-vs-Weekly Drinker
6.444200E-01
Daily Drinker-vs-Occasional Drinker
1.957690E-02
Daily Drinker-vs-Social Drinker
1.235370E-01
Weekly Drinker-vs-Occasional Drinker
1.020010E-01
Weekly Drinker-vs-Social Drinker
3.304200E-01
Occasional Drinker-vs-Social Drinker
5.941400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.559800E-01
Normal-vs-Grade 2
1.944410E-01
Normal-vs-Grade 3
6.977600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.390200E-01
Grade 1-vs-Grade 3
2.235600E-01
Grade 1-vs-Grade 4
2.559800E-01
Grade 2-vs-Grade 3
3.693000E-01
Grade 2-vs-Grade 4
1.944410E-01
Grade 3-vs-Grade 4
6.977600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.126080E-02
Normal-vs-NonDiabetic
4.934200E-02
Diabetic-vs-NonDiabetic
2.574600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.148360E-02
Normal-vs-NoPancreatitis
4.751700E-02
Pancreatitis-vs-NoPancreatitis
1.069450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.664100E-02
Normal-vs-N1
4.716000E-02
N0-vs-N1
6.868200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.880100E-02
Normal-vs-TP53-NonMutant
1.488160E-01
TP53-Mutant-vs-TP53-NonMutant
1.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
